Don Jackson
Hematology & Oncology · Hendersonville, NCNPI 1154361699
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,440 of the $3,837 with a category attached, or 89.7%. It is spread thinly across 36 manufacturers, the largest accounting for just 13.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,858 and has fallen 95.6% since, to $126 in 2022.
Across 233 payments — averaging $16.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$525
- E.r. Squibb & Sons, L.L.C.$301
- Novartis$299
- Pfizer$297
- Merck$292
- Amgen$214
- plus $2K from 30 others
What the payments were for
- Food & beverage$3,44090%
- Education$39710%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 17 | $525 |
| E.r. Squibb & Sons, L.L.C. | 25 | $301 |
| Novartis | 16 | $299 |
| Pfizer | 24 | $297 |
| Merck | 21 | $292 |
| Amgen | 15 | $214 |
| AstraZeneca(2 entities) | 11 | $190 |
| Bayer | 10 | $142 |
| Incyte Corporation | 7 | $134 |
| Daiichi Sankyo Inc. | 7 | $131 |
| Seagen Inc. | 8 | $123 |
| Genentech USA, Inc. | 8 | $115 |
| Gilead(2 entities) | 6 | $113 |
| Rigel Pharmaceuticals, Inc. | 6 | $109 |
| Sanofi | 7 | $106 |
| Lilly USA, LLC | 7 | $105 |
| Tesaro, Inc. | 4 | $97 |
| Exelixis Inc. | 5 | $82 |
| Taiho Oncology, Inc. | 4 | $62 |
| Bristol Myers Squibb | 3 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $42 |
| Kyowa Kirin, Inc. | 2 | $31 |
| Pharmacyclics LLC, An Abbvie Company | 2 | $31 |
| Tersera Therapeutics LLC | 1 | $29 |
| Astellas Pharma US Inc | 2 | $28 |
| Tactile Systems Technology Inc | 1 | $28 |
| Teva Pharmaceuticals USA, Inc. | 2 | $24 |
| Ipsen Biopharmaceuticals, Inc | 1 | $23 |
| Karyopharm Therapeutics Inc. | 1 | $18 |
| Eisai Inc. | 1 | $18 |
| Advanced Accelerator Applications | 1 | $16 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $16 |
| Boehringer Ingelheim | 1 | $14 |
| Array Biopharma Inc | 1 | $14 |
| CSL Behring | 1 | $14 |
| EMD Serono, Inc. | 1 | $11 |
How this compares
$3,837 in reported general payments places this provider in the 60th percentile of 358 hematology & oncology providers in North Carolina.
Other hematology & oncology in Hendersonville
- Amit MehtaCary$4.3M
- Michael MorseDurham$2.6M
- Shelbi AtrashCharlotte$994K
- Phillip FebboDurham$749K
- Angela AlistarWinston Salem$509K
- Ravi PaluriWinston Salem$314K
- Matthew McKinneyDurham$277K
- Jared WeissChapel Hill$217K
- Joshua ZeidnerChapel Hill$208K
- Taewoong ChoiDurham$207K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.